Market access

Results: 1 - 5 of 5

Outcomes-based managed entry agreements (MEAs) can enable patient access to promising high cost...

The HE&MA function of the CGT Catapult engaged with an ATMP developer to identify the US...

A key challenge for the commercial viability of ATMPs is achieving both a high price and...

Understanding how price, revenue and profit margins can be maximised is key to any commercial...

In response to the lack of sufficient information on market access processes for cell and gene...

  • What have our advanced therapies apprentices taken away from their cohort experience? Find out in this Q&A… https://t.co/EHCuBmaxuG 22 hours 34 min ago

Discover who we are